Nucleus Genomics DNA Analysis and Whole-Genome Sequencing Service

Nucleus Genomics has launched its DNA analysis product for personalized genetic risk and health reports. Customers who've previously done microarray genetic testing with other companies can upload their DNA data onto Nucleus' platform to receive greater insights into their genetic risk for diseases like type 2 diabetes and breast cancer. Nucleus also integrates personal and lifestyle factors such as age, cholesterol levels, blood pressure, and BMI into its analysis.

The company is also taking pre-orders for its clinical-grade whole-genome sequencing (WGS) service with plans to begin making these more comprehensive results available in the summer. For a yearly membership fee of $39, members will receive access to new features on Nucleus' platform, as well as new disease reports and, eventually, reports for traits like height and muscle strength. The 30x WGS kit costs $399, the company said.